Results 261 to 270 of about 32,295 (302)
Some of the next articles are maybe not open access.
Management of treatment resistance in schizophrenia
Biological Psychiatry, 2001A systematic approach to the evaluation and characterization of treatment resistance in schizophrenia has become increasingly important since the introduction of the second-generation antipsychotics. The need for accurate evaluation will increase further as other new antipsychotic medications are developed. Patients with schizophrenia may manifest poor
R R, Conley, D L, Kelly
openaire +2 more sources
Treatment-Resistant Schizophrenia
The Primary Care Companion For CNS DisordersThe Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who ...
Carol S, Lim +5 more
+5 more sources
Insulin Resistance in Schizophrenia
2019Schizophrenia and diabetes have been known to be linked disorders for decades. One reason is due to the fact that a major side effect of antipsychotic medication treatment is metabolic syndrome, which increases the risk of the patients developing type 2 diabetes and cardiovascular disorders.
openaire +2 more sources
Schizophrenia resistance ( is there a difference?)
Egyptian Journal of Psychiatry, 2013Background Schizophrenia is a chronic disease of the body and mind that affects 1% of the population. About one-fifth to one-third of all patients with schizophrenia do not respond adequately to drug treatment and that have been consistent over time.
Mamdoh ElGamal +2 more
openaire +1 more source
An approach to treatment resistance in schizophrenia
British Journal of Psychiatry, 1999Currently, patients with schizophrenia are usually considered refractory to treatment if they continue to be floridly symptomatic despite receiving treatment with conventional antipsychotic agents. Attempts to improve their response by increasing the dosage, adding supplementary drugs, or switching to agents of another class have not been very ...
openaire +2 more sources
Treatment resistance in schizophrenia
Psychiatry, 2005Abstract In a substantial proportion of people with schizophrenia the illness shows a poor response to antipsychotic medication. Failure to achieve remission even after the first episode is limited to relatively few cases, and more commonly patients become progressively unresponsive to medication.
Thomas R.E. Barnes, Serdar Dursun
openaire +1 more source
Treatment-Resistant Schizophrenia
2019A significant minority of patients (about one quarter to one third) will have a poor response to first-line antipsychotics and be considered treatment-resistant. In this chapter, I outline a sequential approach to treatment-resistant schizophrenia.
openaire +1 more source
A case of resistant schizophrenia
2013Bollettino della Società Medico Chirurgica di Pavia, Vol 126, N° 3 (2013)
Oliani, Daniela Maria +4 more
openaire +1 more source
Managing resistant schizophrenia.
British journal of hospital medicine, 1994Approximately 25% of patients with schizophrenia remain actively psychotic despite treatment with conventional antipsychotic medication. Many of these patients become new long-stay patients or are frequent readmissions to psychiatric hospitals. This article reviews some of the causes of treatment resistance and the management of this group of patients.
P L, Huckle, S S, Palia
openaire +1 more source
[Clozapine and resistant schizophrenia].
L'Encephale, 1990Clozapine is an atypical antipsychotic drug, with distinguishing features from neuroleptics which are believed to exert their therapeutic effect by blocking dopamine receptors in the limbic system. Clozapine is both chemically and pharmacologically distinct from neuroleptics such as chlorpromazine and haloperidol.
J J, Pere, D, Chaumet-Riffaud
openaire +1 more source